Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurophysiol
2016 Dec 01;1166:2663-2675. doi: 10.1152/jn.00243.2016.
Show Gene links
Show Anatomy links
α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit.
Townsend M
,
Whyment A
,
Walczak JS
,
Jeggo R
,
van den Top M
,
Flood DG
,
Leventhal L
,
Patzke H
,
Koenig G
.
???displayArticle.abstract???
Agonists of the α7-nicotinic acetylcholine receptor (α7-nAChR) have entered clinical trials as procognitive agents for treating schizophrenia and Alzheimer's disease. The most advanced compounds are orthosteric agonists, which occupy the ligand binding site. At the molecular level, agonist activation of α7-nAChR is reasonably well understood. However, the consequences of activating α7-nAChRs on neural circuits underlying cognition remain elusive. Here we report that an α7-nAChR agonist (FRM-17848) enhances long-term potentiation (LTP) in rat septo-hippocampal slices far below the cellular EC50 but at a concentration that coincides with multiple functional outcome measures as we reported in Stoiljkovic M, Leventhal L, Chen A, Chen T, Driscoll R, Flood D, Hodgdon H, Hurst R, Nagy D, Piser T, Tang C, Townsend M, Tu Z, Bertrand D, Koenig G, Hajós M. Biochem Pharmacol 97: 576-589, 2015. In this same concentration range, we observed a significant increase in spontaneous γ-aminobutyric acid (GABA) inhibitory postsynaptic currents and a moderate suppression of excitability in whole cell recordings from rat CA1 pyramidal neurons. This modulation of GABAergic activity is necessary for the LTP-enhancing effects of FRM-17848, since inhibiting GABAA α5-subunit-containing receptors fully reversed the effects of the α7-nAChR agonist. These data suggest that α7-nAChR agonists may increase synaptic plasticity in hippocampal slices, at least in part, through a circuit-level enhancement of a specific subtype of GABAergic receptor.
Aizenman,
Polarity of long-term synaptic gain change is related to postsynaptic spike firing at a cerebellar inhibitory synapse.
1998, Pubmed
Aizenman,
Polarity of long-term synaptic gain change is related to postsynaptic spike firing at a cerebellar inhibitory synapse.
1998,
Pubmed
Albuquerque,
Mammalian nicotinic acetylcholine receptors: from structure to function.
2009,
Pubmed
Alkondon,
Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices.
1997,
Pubmed
Anand,
Therapeutics of Alzheimer's disease: Past, present and future.
2014,
Pubmed
Atack,
GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
2011,
Pubmed
Bartus,
The cholinergic hypothesis of geriatric memory dysfunction.
1982,
Pubmed
Bitner,
In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
2010,
Pubmed
Biton,
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
2007,
Pubmed
,
Xenbase
Brown,
Clinical studies of induction agents. XXV. Diazepam.
1968,
Pubmed
Caraiscos,
Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors.
2004,
Pubmed
Changeux,
Functional organisation of the nicotinic acetylcholine receptor.
1992,
Pubmed
Cheng,
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.
1973,
Pubmed
Clarke,
The amnesic effect of diazepam (Valium).
1970,
Pubmed
Dale,
Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.
2014,
Pubmed
Dani,
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system.
2007,
Pubmed
Deutsch,
Therapeutic implications of a selective alpha7 nicotinic receptor abnormality in schizophrenia.
2005,
Pubmed
Drexler,
Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states.
2013,
Pubmed
Drisdel,
Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers.
2000,
Pubmed
Fabian-Fine,
Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.
2001,
Pubmed
Farzampour,
Endozepines.
2015,
Pubmed
Frazier,
Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells.
1998,
Pubmed
Freedman,
Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression.
1993,
Pubmed
Gault,
Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects.
2003,
Pubmed
Gomolin,
Donepezil dosing strategies: pharmacokinetic considerations.
2011,
Pubmed
Griguoli,
In hippocampal oriens interneurons anti-Hebbian long-term potentiation requires cholinergic signaling via α7 nicotinic acetylcholine receptors.
2013,
Pubmed
Gu,
Cholinergic coordination of presynaptic and postsynaptic activity induces timing-dependent hippocampal synaptic plasticity.
2012,
Pubmed
Guillozet-Bongaarts,
Altered gene expression in the dorsolateral prefrontal cortex of individuals with schizophrenia.
2014,
Pubmed
Hajós,
The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.
2005,
Pubmed
Halff,
A novel mechanism for nicotinic potentiation of glutamatergic synapses.
2014,
Pubmed
Hogg,
An automated system for intracellular and intranuclear injection.
2008,
Pubmed
,
Xenbase
Hurst,
A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
2005,
Pubmed
,
Xenbase
Izquierdo,
Pharmacological evidence for a role of long-term potentiation in memory.
1994,
Pubmed
Johnstone,
Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition.
2011,
Pubmed
,
Xenbase
Jones,
Area and lamina-specific expression of GABAA receptor subunit mRNAs in monkey cerebral cortex.
1997,
Pubmed
Kapai,
Donepezil in a narrow concentration range augments control and impaired by beta-amyloid peptide hippocampal LTP in NMDAR-independent manner.
2012,
Pubmed
Kawai,
Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins.
2002,
Pubmed
Keefe,
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.
2015,
Pubmed
Koh,
Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment.
2013,
Pubmed
Kroker,
Differential effects of subtype-specific nicotinic acetylcholine receptor agonists on early and late hippocampal LTP.
2011,
Pubmed
Lagostena,
The partial alpha7 nicotine acetylcholine receptor agonist S 24795 enhances long-term potentiation at CA3-CA1 synapses in the adult mouse hippocampus.
2008,
Pubmed
Larson,
Induction of synaptic potentiation in hippocampus by patterned stimulation involves two events.
1986,
Pubmed
Lisman,
Bursts as a unit of neural information: making unreliable synapses reliable.
1997,
Pubmed
Marks,
Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin.
1986,
Pubmed
Medeiros,
α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
2014,
Pubmed
Meyer,
Analysis of 3-(4-hydroxy, 2-Methoxybenzylidene)anabaseine selectivity and activity at human and rat alpha-7 nicotinic receptors.
1998,
Pubmed
,
Xenbase
Mukhtasimova,
Detection and trapping of intermediate states priming nicotinic receptor channel opening.
2009,
Pubmed
Neri,
Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia.
2012,
Pubmed
Ondrejcak,
Activation of α7 nicotinic acetylcholine receptors persistently enhances hippocampal synaptic transmission and prevents Aß-mediated inhibition of LTP in the rat hippocampus.
2012,
Pubmed
Palma,
Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine.
1996,
Pubmed
,
Xenbase
Papke,
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
2011,
Pubmed
,
Xenbase
Papke,
The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes.
1998,
Pubmed
,
Xenbase
Prickaerts,
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
2012,
Pubmed
Quik,
Modulation of alpha7 nicotinic receptor-mediated calcium influx by nicotinic agonists.
1997,
Pubmed
Reznic,
Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat.
1997,
Pubmed
Sah,
Apical dendritic location of slow afterhyperpolarization current in hippocampal pyramidal neurons: implications for the integration of long-term potentiation.
1996,
Pubmed
Savić,
Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?
2010,
Pubmed
,
Xenbase
Seltzer,
Donepezil: a review.
2005,
Pubmed
Serwanski,
Synaptic and nonsynaptic localization of GABAA receptors containing the alpha5 subunit in the rat brain.
2006,
Pubmed
Sharma,
Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores.
2001,
Pubmed
Sinkus,
The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.
2015,
Pubmed
Stoiljkovic,
Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays.
2015,
Pubmed
,
Xenbase
Tang,
Neuropharmacokinetics of two investigational compounds in rats: divergent temporal profiles in the brain and cerebrospinal fluid.
2014,
Pubmed
Toyohara,
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.
2010,
Pubmed
Wallace,
Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.
2011,
Pubmed
Werkheiser,
Ultra-low exposure to α-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in α-7 receptor expression in rodents: implications for low dose clinical efficacy.
2011,
Pubmed
Whitehouse,
The cholinergic deficit in Alzheimer's disease.
1998,
Pubmed
Yang,
Concentration of donepezil to the cognitive response in Alzheimer disease.
2013,
Pubmed
Yang,
Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex.
2013,
Pubmed
del Cerro,
Benzodiazepines block long-term potentiation in slices of hippocampus and piriform cortex.
1992,
Pubmed
